Physician profile
Patrick B Curran
NPI 1003077926
$3,436.06
in general payments reported to CMS, 2019-2025
7 companies · $499 in 2025
The $499 reported for 2025 was more than what 77% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $125 · 2021: $389 · 2022: $516 · 2023: $636 · 2024: $849 · 2025: $499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,984.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,984.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,739.87 | 2019-2025 | Myday Contact Lens, Biofinity Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $1,398.46 | 2019-2025 | Precision 1, Total30, Dailies Total1 |
| Harrow Eye, LLC | $122.20 | 2024 | Vevye |
| Mallinckrodt Hospital Products INC. | $116.13 | 2022-2023 | Acthar |
| Bausch & Lomb Americas INC. | $29.54 | 2022 | |
| Kala Pharmaceuticals, INC. | $17.99 | 2022 | |
| Shire North American Group INC | $11.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Curran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.